3M (MMM) Company Report

CEO Bill Brown reiterated 3M’s three priorities—growth, operational performance, and capital deployment—highlighting progress toward targets of $1 bn macro-adjusted growth, 25% operating margin by 2027, and $10 bn cash returns over three years.
Innovation engine revitalized: 196 new product launches in the first nine months (up 70% YoY), projected ~250 for the full year (double two years ago), with five-year new product sales up 16% YTD and a vitality index aiming for 20% by 2027.
Commercial excellence initiative driving SIBG turnaround from –6% to +4% growth over 11 quarters; over $120 m in cross-sell opportunities and $30 m annualized wins, with global rollout to other segments under way.
Operating margin expanded 220 bps YTD, led by G&A productivity gains and quality-cost reduction to 5.7% of COGS (down $100 m YoY), with 2024 margin at 21.4% and target 25% by 2027.
Cash conversion at >100% of net income in 2025 expected to sustain through 2026; inventory at 100 days vs. 75-day target; $4 bn returned via buybacks YTD, $600 m in growth investments, ~1× leverage maintained, and passive Solventum stake to be monetized within five years.

17 hours ago

Transcript

3M outlines growth strategy and operational improvements at Goldman Sachs Industrials & Materials Conference 2025

MMM

Guidance Update

New Projects/Investments

Innovation acceleration: launched 196 products in the first nine months (up 70% YoY) and expects ~250 launches for 2025, with a vitality index rising from 10% to 12% YTD and pipeline additions outpacing launches.
Commercial excellence gains: implemented sales‐force rigor, channel cross‐selling initiatives and AI‐driven churn reduction, driving SIBG growth from –6% to +4% over 11 quarters.
2026 outlook: planning for macro conditions similar to the 2025 exit rate, aiming to outgrow the market via innovation and productivity, targeting high-single-digit EPS growth and on track to 2027 margin goals.
Productivity and margin expansion: achieved 220 bps YTD operating margin improvement (ahead of 2027 target pace) through G&A cost savings and quality‐cost reductions (down ~$100 M, now 5.7% of COGS, targeting <4%).

17 hours ago

Transcript

3M announces Q3 2025 results

MMM

Earnings

Guidance Update

Share Buyback

3M reported Q3 sales of $6.318 B with 3.2% organic growth, an operating margin of 24.7%, EPS of $2.19, and free cash flow of $1.3 B (111% conversion).
Updated full-year guidance: organic sales growth >2%, operating margin expansion of 180–200 bps, EPS of $7.95–$8.05, and free cash flow conversion >100%.
Returned $0.9 B in capital to shareholders in Q3 ( $0.5 B share repurchases, $0.4 B dividends), totaling $3.9 B YTD.

Oct 21, 2025, 1:00 PM

Presentation

3M reports Q3 2025 results

MMM

Earnings

Guidance Update

Share Buyback

3M delivered 3.2% organic sales growth, 24.7% adjusted operating margin (up 170 bp), and EPS of $2.19 (up 10%) in Q3, with $1.3 billion free cash flow (111% conversion); raised full-year EPS guidance to $7.95–$8.05 and expects >2% organic growth and >100% free cash flow conversion for 2025.
All three segments accelerated growth: Safety & Industrial (SIBG) at 4.1%, Transportation & Electronics (TEBG) at 3.6%, and Consumer (CBG) at 0.3%.
Returned $900 million to shareholders in Q3 ($400 million dividends, $500 million share repurchases), totaling $3.9 billion YTD; agreed to divest its precision grinding and finishing business (≈1% of sales) with no earnings dilution.
Continued emphasis on commercial excellence, launching 70 new products in Q3 (196 YTD) and targeting 250+ launches in 2025, while driving operational improvements (OTIF 91.6%, cost of poor quality 5.7%).

Oct 21, 2025, 1:00 PM

Transcript

3M reports Q3 2025 results and raises full-year guidance

MMM

Earnings

Guidance Update

3M delivered GAAP sales of $6.5 billion, up 3.5% YoY, with a GAAP operating margin of 22.2% (+130 bps) and GAAP EPS of $1.55 for Q3 2025.
On an adjusted basis, 3M achieved sales of $6.3 billion (+4.1% YoY) with organic growth of 3.2%, an adjusted operating margin of 24.7% (+170 bps), and adjusted EPS of $2.19 (+10% YoY).
Operating cash flow reached $1.8 billion, producing adjusted free cash flow of $1.3 billion, and the company returned $0.9 billion to shareholders through dividends and buybacks.
3M raised its full-year 2025 outlook to adjusted EPS of $7.95–$8.05 and expects adjusted operating margin expansion of 180–200 bps.

Oct 21, 2025, 10:33 AM

8-K

3M reports Q3 2025 results and raises full-year guidance

MMM

Earnings

Guidance Update

3M posted GAAP sales of $6.5 billion, up 3.5% YoY, with a 22.2% operating margin and GAAP EPS of $1.55 (down 38% YoY) in Q3 2025.
Adjusted sales were $6.3 billion with 3.2% organic growth, an adjusted operating margin of 24.7% (up 170 bps) and adjusted EPS of $2.19 (up 10% YoY).
Generated $1.8 billion in operating cash flow, $1.3 billion of adjusted free cash flow, and returned $0.9 billion to shareholders via dividends and share repurchases.
Increased 2025 adjusted EPS guidance to $7.95–$8.05 and expects adjusted operating cash flow of $5.2–$5.4 billion.

Oct 21, 2025, 10:30 AM

Press Release

3M raises 2025 profit forecast following Q3 earnings beat

MMM

Earnings

Guidance Update

3M raised its full-year 2025 adjusted EPS guidance to $7.95–$8.05, surpassing prior forecasts.
Q3 results featured EPS of $2.19 on $6.3 billion revenue, beating analyst expectations.
Shares closed at $154.78, up 17.5% over the last 12 months and 3.67% in the past three months.
Analysts remain optimistic, with several maintaining overweight or neutral ratings and boosting price targets (e.g., JPMorgan $178; Wells Fargo $176).
Strategic actions include cost-cutting, potential divestiture of industrial units, and a planned spin-off of the healthcare business to sharpen focus and margins.

Oct 20, 2025, 3:24 PM

Bloomberg

3M explores industrial asset divestitures

MMM

M&A

3M Co. is assessing the potential sale of billions of dollars in industrial assets to divest low-growth operations and streamline its portfolio
The company is in discussions with Goldman Sachs, but no final decision has been reached
The move follows the spin-off of healthcare arm Solventum and aligns with CEO William Brown’s push to refocus R&D on product innovation and improve commercialization
The safety and industrials unit generated about $11 billion in revenue last year, and all three business groups have posted organic sales growth over the past three quarters
3M has faced a -9.7% three-year revenue growth decline, an operating margin of 19.47%, a net margin of 16.01%, and a debt-to-equity ratio of 3.2, underscoring profitability and leverage challenges

Oct 4, 2025, 1:23 AM

Bloomberg

3M outlines growth and margin acceleration at Morgan Stanley Laguna Conference

MMM

Guidance Update

Revenue Acceleration/Inflection

3M launched 126 new products in H1 2025, up 70% YoY and on track for >215 launches this year toward its goal of 1,000 over three years.
Commercial excellence in the Safety & Industrial Business Group drove 2.5% organic growth in H1 2025, versus negative growth in H1 2024.
Operating margins expanded 250 bps in H1; full-year guidance is 150–200 bps of margin improvement, targeting 25% by 2027 (up 360 bps from 2024).
Raised 2025 organic growth guidance to 2% (with ~2.5% in H2) and aims for ~3% long-term growth, supported by portfolio shifts into higher-growth segments.
Strategic portfolio review flags ~10% of profit centers as non-core, with plans to divest 2–3% and reinvest in priority verticals like semiconductors and automotive.

Sep 11, 2025, 7:20 PM

Transcript

3M outlines growth and margin priorities at Morgan Stanley Laguna Conference

MMM

Guidance Update

Legal Proceedings

Launched 126 new products in H1 (vs 128 in all of 2023), on track for >215 launches this year and 1,000 launches over the next three years.
Safety & Industrial Business Group organic growth rose to 2.5% in H1; company-wide margins were up 250 bps vs. last year, with full-year expansion of 150–200 bps, targeting 25% margins by 2027 (from 21.4% in 2024).
Delivered 1.5% organic growth in H1, guiding 2% for the full year (implying ~2.5% in H2) and aiming for ~3% sustainable growth over the next three years, supported by portfolio repositioning.
Conducting a portfolio review to divest ~10% of commodity-like profit centers (targeting 2–3% divestitures) and reinvest in high-growth verticals: semiconductors, data centers, aerospace & defense, electronics, automotive, and safety.
PFAS litigation update: $12.5 billion public water settlement paid over 13 years; New Jersey AG settlement deferring cash payments to 2030–2050; Vermont AG trial moved to November; personal-injury bellwether vacated pending case filings.

Sep 11, 2025, 7:20 PM

Transcript

Earnings Transcripts

Quarterly earnings call transcripts for 3M.

Ask Fintool AI Agent

Get instant answers from SEC filings, earnings calls & more

What did William M. Brown say about margins?What are 3M's strategic priorities?How is 3M positioned vs competitors?How did 3M do last quarter?

Let Fintool AI Agent track 3M's earnings for you

Get instant analysis when filings drop